(Reuters) -Algen Biotechnologies said on Monday it has agreed to grant AstraZeneca ( AZN ) a license to develop gene therapies the U.S.-based biotech discovers using its artificial intelligence-driven platform, in a deal worth up to $555 million. Under the deal, AstraZeneca ( AZN ) will get exclusive rights to develop therapies that target immune system-related disorders. The Anglo-Swedish pharmaceutical...

08:04 AM EDT, 10/06/2025 (MT Newswires) -- Pembina Pipeline ( PBA ) said Monday that it remains focused on advancing the Greenlight Electricity Centre in Alberta with project partner Kineticor, an OPTrust portfolio company. The announcement comes as RBC Capital Markets cited an unconfirmed report that Pembina is close to announcing a data center deal with Meta. The project includes...

Oct 6 (Reuters) - Algen Biotechnologies said on Monday it has agreed to grant AstraZeneca ( AZN ) a license to develop gene therapies the U.S.-based biotech discovers using its artificial intelligence-driven platform, in a deal worth up to $555 million. Under the deal, AstraZeneca ( AZN ) will get exclusive rights to develop therapies that target immune system-related disorders....

MILAN, Oct 6 (Reuters) - RBRItalian furniture maker Natuzzi expects its U.S. revenues to undershoot its target by around 20% and come in at 85-90 million euros in 2025 due to a 15% tariff imposed by the Trump administration on furniture imports, and a weaker dollar. The U.S. market was and remains fundamental for us, and it's hard to replace...